Inventor

Gilbert Vassart

Inventor
Brussels, BE

Overview

19→
Patents
2001–2015
Patent span
Human necessities
Primary field (CPC A)

Patents· 19 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides27%
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
G01NInvestigating or analysing materials by determining their chemical or physical properties17%
A01KAnimal husbandry11%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%
PatentTitleYear
9,040,670'Monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding to their variable regions, and their uses in diagnostic, preventive and therapeutic medicine'20158,501,415'Identification of TSH receptor autoantibodies using affinity-purified antibodies'20138,029,790'Monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding to their variable regions, and their uses in diagnostic, preventive and therapeutic medicine'20118,030,453'Methods of making an antibody that binds a chemerin polypeptide'20118,003,347'Nucleic acids encoding ChemerinR ligands'20117,858,755'Monoclonal antibodies that bind Chemerin polypeptide'20107,842,453'Methods of identifying modulators of ChemerinR polypeptides'20107,666,401'Compositions comprising a ligand of Chemerin R'20107,582,734'Functional antibodies that specifically bind to the Chemerin receptor'20097,470,772'Antibody that specifically binds to Chemerin receptor ligand precursor'20087,419,658'Isolated ligand of ChemerinR'20087,332,291'Methods of identifying modulators of ligand binding to ChemerinR polypeptides'20087,285,390'Screening methods for identifying compounds which decrease HIV entry into a cell'20077,083,932'Nucleic acid molecules encoding peptides having pronociceptive properties'20066,930,174'CCR5 chemokine receptor-specific antibodies'20056,800,447'Methods for identifying compounds which bind the active CCR5 chemokine receptor'20046,692,938'Nucleic acids encoding active and inactive CCR5 chemokine receptors'20046,448,375'Active and inactive CC-chemokine receptor'20026,228,597'Polypeptides having thyrotropin-receptor activity, nucleic acid sequences coding for such receptors and polypeptides, and applications of these polypeptides'2001

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2001–2015Based in Brussels, BE· patent location history
2002–2011Patents assigned to EUROSCREEN SA (15)· patent assignee history
2011–2015Patents assigned to BRAHMS GMBH (3)· patent assignee history
2013–2015Patents assigned to BERGMANN ANDREAS (2)· patent assignee history
2013–2015Patents assigned to COSTAGLIOLA SABINE (2)· patent assignee history
2013–2015Patents assigned to VASSART GILBERT (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
EUROSCREEN SA152002–2011
BRAHMS GMBH32011–2015
BERGMANN ANDREAS22013–2015
COSTAGLIOLA SABINE22013–2015
VASSART GILBERTself22013–2015
Locations
LocationPatentsSpan
Brussels, BE192001–2015